bromodeoxyuridine has been researched along with osu 03012 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, CS; D'Ambrosio, SM; Ding, H; Duan, W; Guo, D; Han, C; Wang, D | 1 |
1 other study(ies) available for bromodeoxyuridine and osu 03012
Article | Year |
---|---|
Sensitivity to the non-COX inhibiting celecoxib derivative, OSU03012, is p21(WAF1/CIP1) dependent.
Topics: Animals; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Blotting, Western; Bromodeoxyuridine; Cell Line; Cyclin A; Cyclin-Dependent Kinase Inhibitor p21; Embryo, Mammalian; Fibroblasts; Flow Cytometry; G1 Phase; Gene Silencing; Humans; Immunoprecipitation; Mice; Mouth Mucosa; Oncogene Proteins, Viral; Papillomaviridae; Papillomavirus E7 Proteins; Papillomavirus Infections; Proto-Oncogene Proteins; Pyrazoles; Repressor Proteins; Sulfonamides; Tumor Virus Infections | 2008 |